SciDev.Net

Vaccines for non-infectious illness could help developing nations tackle the growing burden of chronic disease. Maryke Steffens reports.

Leading geneticist Samir Brahmachari explains why India should kickstart a new open source approach to drug discovery for diseases like TB.

Many factors are increasing antibiotic resistance, and authorities, doctors and patients all have a role in fighting it, writes Jia Hepeng.

As three Andean nations forge ahead with free trade agreements with the United States, Lisbeth Fog reports on the implications for healthcare, research and regional stability.

As production of flu drug Tamiflu gears up, big questions remain over how affordable — and effective — it will be, reports Martin Enserink.

SciDev.Net journalists report on efforts to face bird flu in Africa, the Middle East and Latin America.

India's biotechnology sector is thriving, but K. S. Jayaraman asks whether simply increasing investment will be enough to sustain it.

Jia Hepeng describes how Chinese researchers are changing the way they use herbal remedies to compete on the international pharmaceutical market.

Poorer countries are pioneering creative approaches to health research, from developing new drugs to taking an innovative part in the global pharmaceuticals business, reports Fiona Fleck.